Revisiting DARPP-32 in postmortem human brain: changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expression
Dopamine- and cAMP-regulated phosphoprotein of molecular weight 32 kDa (DARPP-32 or PPP1R1B ) has been of interest in schizophrenia owing to its critical function in integrating dopaminergic and glutaminergic signaling. In a previous study, we identified single-nucleotide polymorphisms (SNPs) and a...
Saved in:
| Published in | Molecular psychiatry Vol. 19; no. 2; pp. 192 - 199 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
01.02.2014
Nature Publishing Group |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Dopamine- and cAMP-regulated phosphoprotein of molecular weight 32 kDa (DARPP-32 or
PPP1R1B
) has been of interest in schizophrenia owing to its critical function in integrating dopaminergic and glutaminergic signaling. In a previous study, we identified single-nucleotide polymorphisms (SNPs) and a frequent haplotype associated with cognitive and imaging phenotypes that have been linked with schizophrenia, as well as with expression of prefrontal cortical DARPP-32 messenger RNA (mRNA) in a relatively small sample of postmortem brains. In this study, we examined the association of expression of two major DARPP-32 transcripts, full-length (FL-DARPP-32) and truncated (t-DARPP-32), with genetic variants of DARPP-32 in three brain regions receiving dopaminergic input and implicated in schizophrenia (the dorsolateral prefrontal cortex (DLPFC), hippocampus and caudate) in a much larger set of postmortem samples from patients with schizophrenia, bipolar disorder, major depression and normal controls (>700 subjects). We found that the expression of t-DARPP-32 was increased in the DLPFC of patients with schizophrenia and bipolar disorder, and was strongly associated with genotypes at SNPs (rs879606, rs90974 and rs3764352), as well as the previously identified 7-SNP haplotype related to cognitive functioning. The genetic variants that predicted worse cognitive performance were associated with higher t-DARPP-32 expression. Our results suggest that variation in
PPP1R1B
affects the abundance of the splice variant t-DARPP-32 mRNA and may reflect potential molecular mechanisms implicated in schizophrenia and affective disorders. |
|---|---|
| AbstractList | Dopamine- and cAMP-regulated phosphoprotein of molecular weight 32 kDa (DARPP-32 or PPP1R1B) has been of interest in schizophrenia owing to its critical function in integrating dopaminergic and glutaminergic signaling. In a previous study, we identified single-nucleotide polymorphisms (SNPs) and a frequent haplotype associated with cognitive and imaging phenotypes that have been linked with schizophrenia, as well as with expression of prefrontal cortical DARPP-32 messenger RNA (mRNA) in a relatively small sample of postmortem brains. In this study, we examined the association of expression of two major DARPP-32 transcripts, full-length (FL-DARPP-32) and truncated (t-DARPP-32), with genetic variants of DARPP-32 in three brain regions receiving dopaminergic input and implicated in schizophrenia (the dorsolateral prefrontal cortex (DLPFC), hippocampus and caudate) in a much larger set of postmortem samples from patients with schizophrenia, bipolar disorder, major depression and normal controls (>700 subjects). We found that the expression of t-DARPP-32 was increased in the DLPFC of patients with schizophrenia and bipolar disorder, and was strongly associated with genotypes at SNPs (rs879606, rs90974 and rs3764352), as well as the previously identified 7-SNP haplotype related to cognitive functioning. The genetic variants that predicted worse cognitive performance were associated with higher t-DARPP-32 expression. Our results suggest that variation in PPP1R1B affects the abundance of the splice variant t-DARPP-32 mRNA and may reflect potential molecular mechanisms implicated in schizophrenia and affective disorders. Dopamine- and cAMP-regulated phosphoprotein of molecular weight 32 kDa (DARPP-32 or PPP1R1B) has been of interest in schizophrenia owing to its critical function in integrating dopaminergic and glutaminergic signaling. In a previous study, we identified single-nucleotide polymorphisms (SNPs) and a frequent haplotype associated with cognitive and imaging phenotypes that have been linked with schizophrenia, as well as with expression of prefrontal cortical DARPP-32 messenger RNA (mRNA) in a relatively small sample of postmortem brains. In this study, we examined the association of expression of two major DARPP-32 transcripts, full-length (FL-DARPP-32) and truncated (t-DARPP-32), with genetic variants of DARPP-32 in three brain regions receiving dopaminergic input and implicated in schizophrenia (the dorsolateral prefrontal cortex (DLPFC), hippocampus and caudate) in a much larger set of postmortem samples from patients with schizophrenia, bipolar disorder, major depression and normal controls (>700 subjects). We found that the expression of t-DARPP-32 was increased in the DLPFC of patients with schizophrenia and bipolar disorder, and was strongly associated with genotypes at SNPs (rs879606, rs90974 and rs3764352), as well as the previously identified 7-SNP haplotype related to cognitive functioning. The genetic variants that predicted worse cognitive performance were associated with higher t-DARPP-32 expression. Our results suggest that variation in PPP1RW affects the abundance of the splice variant t-DARPP-32 mRNA and may reflect potential molecular mechanisms implicated in schizophrenia and affective disorders. Molecular Psychiatry (2014) 19, 192-199; doi: 10.1038/mp.2012.174; published online 8 January 2013 Keywords: bipolar disorder; DARPP-32; dopamine; postmortem brain; schizophrenia; truncated Dopamine- and cAMP-regulated phosphoprotein of molecular weight 32 kDa (DARPP-32 or PPP1R1B) has been of interest in schizophrenia owing to its critical function in integrating dopaminergic and glutaminergic signaling. In a previous study, we identified single-nucleotide polymorphisms (SNPs) and a frequent haplotype associated with cognitive and imaging phenotypes that have been linked with schizophrenia, as well as with expression of prefrontal cortical DARPP-32 messenger RNA (mRNA) in a relatively small sample of postmortem brains. In this study, we examined the association of expression of two major DARPP-32 transcripts, full-length (FL-DARPP-32) and truncated (t-DARPP-32), with genetic variants of DARPP-32 in three brain regions receiving dopaminergic input and implicated in schizophrenia (the dorsolateral prefrontal cortex (DLPFC), hippocampus and caudate) in a much larger set of postmortem samples from patients with schizophrenia, bipolar disorder, major depression and normal controls (>700 subjects). We found that the expression of t-DARPP-32 was increased in the DLPFC of patients with schizophrenia and bipolar disorder, and was strongly associated with genotypes at SNPs (rs879606, rs90974 and rs3764352), as well as the previously identified 7-SNP haplotype related to cognitive functioning. The genetic variants that predicted worse cognitive performance were associated with higher t-DARPP-32 expression. Our results suggest that variation in PPP1R1B affects the abundance of the splice variant t-DARPP-32 mRNA and may reflect potential molecular mechanisms implicated in schizophrenia and affective disorders.Dopamine- and cAMP-regulated phosphoprotein of molecular weight 32 kDa (DARPP-32 or PPP1R1B) has been of interest in schizophrenia owing to its critical function in integrating dopaminergic and glutaminergic signaling. In a previous study, we identified single-nucleotide polymorphisms (SNPs) and a frequent haplotype associated with cognitive and imaging phenotypes that have been linked with schizophrenia, as well as with expression of prefrontal cortical DARPP-32 messenger RNA (mRNA) in a relatively small sample of postmortem brains. In this study, we examined the association of expression of two major DARPP-32 transcripts, full-length (FL-DARPP-32) and truncated (t-DARPP-32), with genetic variants of DARPP-32 in three brain regions receiving dopaminergic input and implicated in schizophrenia (the dorsolateral prefrontal cortex (DLPFC), hippocampus and caudate) in a much larger set of postmortem samples from patients with schizophrenia, bipolar disorder, major depression and normal controls (>700 subjects). We found that the expression of t-DARPP-32 was increased in the DLPFC of patients with schizophrenia and bipolar disorder, and was strongly associated with genotypes at SNPs (rs879606, rs90974 and rs3764352), as well as the previously identified 7-SNP haplotype related to cognitive functioning. The genetic variants that predicted worse cognitive performance were associated with higher t-DARPP-32 expression. Our results suggest that variation in PPP1R1B affects the abundance of the splice variant t-DARPP-32 mRNA and may reflect potential molecular mechanisms implicated in schizophrenia and affective disorders. Dopamine- and cAMP-regulated phosphoprotein of molecular weight 32 kDa (DARPP-32 or PPP1R1B) has been of interest in schizophrenia owing to its critical function in integrating dopaminergic and glutaminergic signaling. In a previous study, we identified single-nucleotide polymorphisms (SNPs) and a frequent haplotype associated with cognitive and imaging phenotypes that have been linked with schizophrenia, as well as with expression of prefrontal cortical DARPP-32 messenger RNA (mRNA) in a relatively small sample of postmortem brains. In this study, we examined the association of expression of two major DARPP-32 transcripts, full-length (FL-DARPP-32) and truncated (t-DARPP-32), with genetic variants of DARPP-32 in three brain regions receiving dopaminergic input and implicated in schizophrenia (the dorsolateral prefrontal cortex (DLPFC), hippocampus and caudate) in a much larger set of postmortem samples from patients with schizophrenia, bipolar disorder, major depression and normal controls (>700 subjects). We found that the expression of t-DARPP-32 was increased in the DLPFC of patients with schizophrenia and bipolar disorder, and was strongly associated with genotypes at SNPs (rs879606, rs90974 and rs3764352), as well as the previously identified 7-SNP haplotype related to cognitive functioning. The genetic variants that predicted worse cognitive performance were associated with higher t-DARPP-32 expression. Our results suggest that variation in PPP1RW affects the abundance of the splice variant t-DARPP-32 mRNA and may reflect potential molecular mechanisms implicated in schizophrenia and affective disorders. Dopamine- and cAMP-regulated phosphoprotein of molecular weight 32 kDa (DARPP-32 or PPP1R1B ) has been of interest in schizophrenia owing to its critical function in integrating dopaminergic and glutaminergic signaling. In a previous study, we identified single-nucleotide polymorphisms (SNPs) and a frequent haplotype associated with cognitive and imaging phenotypes that have been linked with schizophrenia, as well as with expression of prefrontal cortical DARPP-32 messenger RNA (mRNA) in a relatively small sample of postmortem brains. In this study, we examined the association of expression of two major DARPP-32 transcripts, full-length (FL-DARPP-32) and truncated (t-DARPP-32), with genetic variants of DARPP-32 in three brain regions receiving dopaminergic input and implicated in schizophrenia (the dorsolateral prefrontal cortex (DLPFC), hippocampus and caudate) in a much larger set of postmortem samples from patients with schizophrenia, bipolar disorder, major depression and normal controls (>700 subjects). We found that the expression of t-DARPP-32 was increased in the DLPFC of patients with schizophrenia and bipolar disorder, and was strongly associated with genotypes at SNPs (rs879606, rs90974 and rs3764352), as well as the previously identified 7-SNP haplotype related to cognitive functioning. The genetic variants that predicted worse cognitive performance were associated with higher t-DARPP-32 expression. Our results suggest that variation in PPP1R1B affects the abundance of the splice variant t-DARPP-32 mRNA and may reflect potential molecular mechanisms implicated in schizophrenia and affective disorders. |
| Audience | Academic |
| Author | Ye, T Dickinson, D Kolachana, B Kleinman, J E Hyde, T M Lipska, B K Weinberger, D R Li, C Kunii, Y |
| Author_xml | – sequence: 1 givenname: Y surname: Kunii fullname: Kunii, Y organization: Division of Intramural Research Programs, Section on Neuropathology, Clinical Brain Disorders Branch, Genes Cognition and Psychosis Program, National Institute of Mental Health, Department of Neuropsychiatry, Fukushima Medical University School of Medicine – sequence: 2 givenname: T M surname: Hyde fullname: Hyde, T M organization: Division of Intramural Research Programs, Section on Neuropathology, Clinical Brain Disorders Branch, Genes Cognition and Psychosis Program, National Institute of Mental Health, Lieber Institute for Brain Development, Johns Hopkins Medical Campus – sequence: 3 givenname: T surname: Ye fullname: Ye, T organization: Division of Intramural Research Programs, Section on Neuropathology, Clinical Brain Disorders Branch, Genes Cognition and Psychosis Program, National Institute of Mental Health, Lieber Institute for Brain Development, Johns Hopkins Medical Campus – sequence: 4 givenname: C surname: Li fullname: Li, C organization: Division of Intramural Research Programs, Section on Neuropathology, Clinical Brain Disorders Branch, Genes Cognition and Psychosis Program, National Institute of Mental Health – sequence: 5 givenname: B surname: Kolachana fullname: Kolachana, B organization: Division of Intramural Research Programs, Section on Neuropathology, Clinical Brain Disorders Branch, Genes Cognition and Psychosis Program, National Institute of Mental Health – sequence: 6 givenname: D surname: Dickinson fullname: Dickinson, D organization: Division of Intramural Research Programs, Section on Neuropathology, Clinical Brain Disorders Branch, Genes Cognition and Psychosis Program, National Institute of Mental Health – sequence: 7 givenname: D R surname: Weinberger fullname: Weinberger, D R organization: Division of Intramural Research Programs, Section on Neuropathology, Clinical Brain Disorders Branch, Genes Cognition and Psychosis Program, National Institute of Mental Health, Lieber Institute for Brain Development, Johns Hopkins Medical Campus – sequence: 8 givenname: J E surname: Kleinman fullname: Kleinman, J E organization: Division of Intramural Research Programs, Section on Neuropathology, Clinical Brain Disorders Branch, Genes Cognition and Psychosis Program, National Institute of Mental Health – sequence: 9 givenname: B K surname: Lipska fullname: Lipska, B K email: lipskab@mail.nih.gov organization: Division of Intramural Research Programs, Section on Neuropathology, Clinical Brain Disorders Branch, Genes Cognition and Psychosis Program, National Institute of Mental Health |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28395577$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/23295814$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkltrFDEUxwep2Is--S4BEQSdNfdkfFvqFQqWos8hk8nspMwkY5L19in8yGa7W61lEclDwjm_8z85yf-4OvDB26p6iOACQSJfTPMCQ4QXSNA71RGigteMCXlQzoQ1NUWSHlbHKV1CuEmye9UhJrhhEtGj6ueF_eKSy86vwKvlxfl5TTBwHswh5SnEbCcwrCftQRu18y-BGbRf2bRBkhncjzAP0XqngfYdaN0cRh1B51KInY1XwZX1NjsDdErBOJ1d8Al8dXkAuf7d0X6bo02p5O5Xd3s9Jvtgt59Un968_nj6rj778Pb96fKsNow2uca672VLaYu5ZByiMiqBUqKGtJBj3Pe6jA0tES3itCeCQUMJ10I0EuuGc3JSPd3qzjF8XtuU1eSSseOovQ3rpBBteNGTmP0PigVkiDUFfXwLvQzr6MsgCnPKBOdIkn9RRQthQTi7Qa30aJXzfchRm01rtSQcoTI3woVa7KHK6uzkTHFK70r8r4JHu-brdrKdmqObdPyurj1RgCc7QCejxz5qb1z6w0nSFH-JwqEtZ2JIKdpeGZev_rfcwI0KQbXxp5pmtfGnKv4sNc9u1VzL7qefb-lUqGK7eOOd9uC_AO9U7uw |
| CitedBy_id | crossref_primary_10_1371_journal_pone_0188537 crossref_primary_10_1038_mp_2013_165 crossref_primary_10_3389_fgene_2022_831221 crossref_primary_10_18632_oncotarget_7268 crossref_primary_10_1016_j_neubiorev_2023_105064 crossref_primary_10_1111_ejn_12600 crossref_primary_10_1093_cercor_bhy062 crossref_primary_10_1016_j_bbr_2021_113407 crossref_primary_10_1093_cercor_bhx253 crossref_primary_10_3390_ijms161226228 crossref_primary_10_3389_fnins_2017_00244 crossref_primary_10_1088_1361_6560_ac9d1e crossref_primary_10_1002_pmic_201600478 crossref_primary_10_1038_tp_2015_45 crossref_primary_10_1016_j_neubiorev_2020_07_037 crossref_primary_10_1038_s41380_018_0293_0 crossref_primary_10_1038_s41598_019_51456_7 crossref_primary_10_1038_tp_2016_261 crossref_primary_10_1016_j_jpsychires_2016_07_018 crossref_primary_10_1002_ar_24732 crossref_primary_10_1038_npp_2016_31 crossref_primary_10_1371_journal_pgen_1008358 crossref_primary_10_18632_oncotarget_17339 crossref_primary_10_1093_bib_bbx157 crossref_primary_10_1016_j_stemcr_2019_07_015 crossref_primary_10_1038_s42003_018_0050_6 crossref_primary_10_3389_fnins_2022_989046 crossref_primary_10_1007_s12264_016_0088_8 crossref_primary_10_1016_j_schres_2014_10_019 crossref_primary_10_1074_jbc_M116_772541 crossref_primary_10_1016_j_pnpbp_2024_111060 crossref_primary_10_1038_s41380_019_0436_y crossref_primary_10_1038_s41380_021_01037_w crossref_primary_10_1186_s40169_017_0174_1 crossref_primary_10_1038_s42003_022_03412_x crossref_primary_10_1007_s12035_017_0834_6 crossref_primary_10_1093_hmg_ddae130 crossref_primary_10_15252_emmm_201910695 crossref_primary_10_1093_scan_nsx089 crossref_primary_10_1016_j_pnpbp_2014_03_014 crossref_primary_10_3389_fnins_2020_582853 crossref_primary_10_1177_0269881114523864 crossref_primary_10_1038_mp_2016_41 crossref_primary_10_18632_oncotarget_5311 crossref_primary_10_7717_peerj_14516 crossref_primary_10_1016_j_neuropharm_2016_12_021 crossref_primary_10_1038_nm_4096 crossref_primary_10_1016_j_neuroscience_2016_07_022 crossref_primary_10_1016_j_bpsgos_2022_03_010 |
| Cites_doi | 10.1111/j.1471-4159.1992.tb08361.x 10.1002/cncr.11654 10.1016/j.psychres.2009.05.014 10.1523/JNEUROSCI.4477-10.2011 10.1146/annurev.pharmtox.44.101802.121415 10.1002/cne.902990306 10.1007/s00795-010-0524-1 10.1086/376547 10.1523/JNEUROSCI.1129-11.2011 10.1016/j.pnpbp.2011.07.010 10.1038/nm.2886 10.1016/j.schres.2006.04.003 10.1371/journal.pone.0006220 10.1038/sj.bjc.6601899 10.1086/376549 10.1176/appi.ajp.162.10.1859 10.1002/syn.20292 10.1677/erc.1.01147 10.1016/j.pnpbp.2007.05.014 10.1093/hmg/ddm347 10.1186/1476-4598-9-240 10.1111/j.1365-2990.2010.01128.x 10.1016/j.schres.2007.10.028 10.1523/JNEUROSCI.04-01-00111.1984 10.1126/science.1167363 10.1016/j.biopsych.2006.06.019 10.1371/journal.pbio.1000001 10.1002/cne.903230206 10.1016/j.neuroscience.2011.08.074 10.1016/0306-4522(95)00037-J 10.1073/pnas.0610765104 10.1016/j.neuint.2010.08.012 10.1001/archpsyc.59.8.705 10.1016/j.neuroimage.2011.08.036 10.1172/JCI30413 10.1016/j.pnpbp.2007.04.013 10.1016/j.bbr.2009.03.032 10.1016/S0002-9440(10)63556-0 10.1523/JNEUROSCI.04-01-00084.1984 10.1073/pnas.0706111104 10.1001/archgenpsychiatry.2010.175 10.1016/j.pnpbp.2011.03.016 10.1158/0008-5472.CAN-07-1580 10.1016/j.biopsych.2010.10.032 10.1016/j.schres.2008.05.014 |
| ContentType | Journal Article |
| Copyright | Macmillan Publishers Limited 2014 2015 INIST-CNRS COPYRIGHT 2014 Nature Publishing Group Copyright Nature Publishing Group Feb 2014 Macmillan Publishers Limited 2014. |
| Copyright_xml | – notice: Macmillan Publishers Limited 2014 – notice: 2015 INIST-CNRS – notice: COPYRIGHT 2014 Nature Publishing Group – notice: Copyright Nature Publishing Group Feb 2014 – notice: Macmillan Publishers Limited 2014. |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7TK 7X7 7XB 88E 88G 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2M M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 8FD FR3 P64 RC3 |
| DOI | 10.1038/mp.2012.174 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database Psychology Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts Genetics Abstracts |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic Genetics Abstracts Engineering Research Database Technology Research Database Biotechnology and BioEngineering Abstracts |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Genetics Abstracts ProQuest One Psychology ProQuest One Psychology |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1476-5578 |
| EndPage | 199 |
| ExternalDocumentID | 3189380141 A361185612 23295814 28395577 10_1038_mp_2012_174 |
| Genre | Journal Article Research Support, N.I.H., Intramural |
| GeographicLocations | United States--US |
| GeographicLocations_xml | – name: United States--US |
| GrantInformation_xml | – fundername: Intramural NIH HHS |
| GroupedDBID | --- -Q- 0R~ 123 29M 2WC 36B 39C 3V. 4.4 406 53G 70F 7X7 88E 8AO 8FI 8FJ 8R4 8R5 AACDK AANZL AASML AATNV AAYZH AAZLF ABAKF ABAWZ ABDBF ABIVO ABJNI ABLJU ABUWG ABZZP ACAOD ACGFS ACKTT ACPRK ACRQY ACUHS ACZOJ ADBBV ADHDB AEFQL AEJRE AEMSY AENEX AEVLU AEXYK AFBBN AFKRA AFRAH AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AIGIU AILAN AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF AXYYD AZQEC B0M BAWUL BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CAG CCPQU COF CS3 DIK DNIVK DPUIP DU5 DWQXO E3Z EAD EAP EBC EBD EBLON EBS EE. EIOEI EJD EMB EMK EMOBN EPL EPS ESX F5P FDQFY FEDTE FERAY FIGPU FIZPM FSGXE FYUFA GNUQQ HCIFZ HMCUK HVGLF HZ~ IAO IHR INH INR IPY ITC IWAJR JSO JZLTJ KQ8 M1P M2M M7P NAO NQJWS O9- OK1 OVD P2P PQQKQ PROAC PSQYO PSYQQ Q2X RNS RNT RNTTT ROL SNX SNYQT SOHCF SOJ SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TEORI TR2 TSG TUS UKHRP ~8M AAYXX ABBRH ABDBE ABFSG ACSTC AEZWR AFDZB AFHIU AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT IQODW CGR CUY CVF ECM EIF NPM AEIIB PMFND 7TK 7XB 8FE 8FH 8FK ABRTQ K9. LK8 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U PUEGO 7X8 8FD FR3 P64 RC3 |
| ID | FETCH-LOGICAL-c549t-2aff8b44b26856011353088193b0622ffa1840e37b164f3750c436a77982a9663 |
| IEDL.DBID | 7X7 |
| ISSN | 1359-4184 1476-5578 |
| IngestDate | Thu Jul 10 19:24:57 EDT 2025 Thu Aug 07 14:36:21 EDT 2025 Sat Aug 23 14:31:22 EDT 2025 Fri Jul 25 08:57:55 EDT 2025 Tue Jun 17 21:19:34 EDT 2025 Tue Jun 10 20:29:36 EDT 2025 Wed Feb 19 01:50:59 EST 2025 Wed Apr 02 07:21:47 EDT 2025 Tue Jul 01 00:21:42 EDT 2025 Thu Apr 24 23:00:19 EDT 2025 Fri Feb 21 02:39:25 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | DARPP-32 postmortem brain truncated bipolar disorder schizophrenia dopamine Mood disorder Human Dopamine Central nervous system Postmortem Schizophrenia Bipolar disorder Catecholamine Encephalon Psychosis Neurotransmitter Genetics |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c549t-2aff8b44b26856011353088193b0622ffa1840e37b164f3750c436a77982a9663 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
| OpenAccessLink | https://www.nature.com/articles/mp2012174.pdf |
| PMID | 23295814 |
| PQID | 1491273653 |
| PQPubID | 44096 |
| PageCount | 8 |
| ParticipantIDs | proquest_miscellaneous_1496881825 proquest_miscellaneous_1492705159 proquest_journals_2645766183 proquest_journals_1491273653 gale_infotracmisc_A361185612 gale_infotracacademiconefile_A361185612 pubmed_primary_23295814 pascalfrancis_primary_28395577 crossref_citationtrail_10_1038_mp_2012_174 crossref_primary_10_1038_mp_2012_174 springer_journals_10_1038_mp_2012_174 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2014-02-01 |
| PublicationDateYYYYMMDD | 2014-02-01 |
| PublicationDate_xml | – month: 02 year: 2014 text: 2014-02-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: Basingstoke – name: England – name: New York |
| PublicationTitle | Molecular psychiatry |
| PublicationTitleAbbrev | Mol Psychiatry |
| PublicationTitleAlternate | Mol Psychiatry |
| PublicationYear | 2014 |
| Publisher | Nature Publishing Group UK Nature Publishing Group |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
| References | Carrera, Arrojo, Paz, Ramos-Ríos, Agra, Páramo (CR36) 2010; 179 Guitart, Nestler (CR47) 1992; 59 Svenningsson, Nishi, Fisone, Girault, Nairn, Greengard (CR1) 2004; 44 Ebihara, Miyamoto, Fukunaga, Kato, Shichinohe, Kawarada (CR16) 2004; 91 Chan, Liu, Pradoldej, Hao, An, Yepes (CR42) 2011; 31 Feldcamp, Souza, Romano-Silva, Kennedy, Wong (CR24) 2008; 103 Ouimet, Lamantia, Goldman-Rakic, Rakic, Greengard (CR6) 1992; 323 Yoshimi, Takahashi, Saito, Ito, Aleksic, Usui (CR34) 2008; 100 Baracskay, Haroutunian, Meador-Woodruff (CR23) 2006; 60 Kunii, Ikemoto, Wada, Yang, Kusakabe, Suzuki (CR22) 2011; 44 Yamada, Gerber, Iwayama, Ohnishi, Ohba, Toyota (CR33) 2007; 104 Meyer-Lindenberg, Straub, Lipska, Verchinski, Goldberg, Callicott (CR12) 2007; 117 Heinzen, Ge, Cronin, Maia, Shianna, Gabriel (CR9) 2008; 6 Talkowski, Kirov, Bamne, Georgieva, Torres, Mansour (CR35) 2008; 17 Alvaro-Bartolomé, La Harpe, Callado, Meana, García-Sevilla (CR48) 2011; 196 Ishikawa, Mizukami, Iwakiri, Asada (CR21) 2007; 31 Beckler, Moskaluk, Zaika, Hampton, Powell, Frierson (CR14) 2003; 98 Hu, Yu, Shi, Zhao, Meng, He (CR32) 2007; 31 Gu, Waliany, Kane (CR40) 2009; 4 Berger, Febvret, Greengard, Goldman-Rakic (CR2) 1990; 229 Kunii, Yabe, Wada, Yang, Nishiura, Niwa (CR27) 2011; 35 Kauraniemi, Kallioniemi (CR18) 2006; 13 Segurado, Detera-Wadleigh, Levinson, Lewis, Gill, Nurnberger (CR30) 2003; 73 Belkhiri, Dar, Zaika, Kelley, El-Rifai (CR43) 2008; 68 Curčić-Blake, Swart, Ter Horst, Langers, Kema, Aleman (CR44) 2012; 59 Konradi, Zimmerman, Yang, Lohmann, Gresch, Pantazopoulos (CR39) 2011; 68 Ouimet, Miller, Hemmings, Walaas, Greengard (CR5) 1984; 4 Kang, Voleti, Hajszan, Rajkowska, Stockmeier, Licznerski (CR38) 2012; 18 Kleinman, Law, Lipska, Hyde, Ellis, Harrison (CR11) 2011; 69 Zhan, Kerr, Lafuente, Maclean, Chibalina, Liu (CR25) 2011; 37 Clinton, Ibrahim, Frey, Davis, Haroutunian, Meador-Woodruff (CR26) 2005; 162 Brene, Hall, Lindefors, Karlson, Halldin, Sedvall (CR3) 1995; 67 El-Rifai, Smith, Li, Beckler, Carl, Montgomery (CR13) 2002; 62 Cuesto, Enriquez-Barreto, Caramés, Cantarero, Gasull, Sandi (CR41) 2011; 31 Kauraniemi, Kuukasjarvi, Sauter, Kallioniemi (CR15) 2003; 163 Frank, Moustafa, Haughey, Curran, Hutchison (CR46) 2007; 104 Wang, Pan, Liu, Guo, Hong, Fan (CR17) 2004; 33 Lewis, Levinson, Wise, DeLisi, Straub, Hovatta (CR29) 2003; 73 Walaas, Greengard (CR4) 1984; 4 Cotton, Auerbach, Axton, Barash, Berkovic, Brookes (CR8) 2008; 322 Lipska, Deep-Soboslay, Weickert, Hyde, Martin, Herman (CR37) 2006; 60 Li, Liao, Hung, Chen (CR31) 2006; 87 Vangamudi, Peng, Cai, El-Rifai, Zheng, Belkhiri (CR19) 2010; 9 Morikawa, Manabe (CR10) 2010; 57 Albert, Hemmings, Adamo, Potkin, Akbarian, Sandman (CR20) 2002; 59 Nishiura, Kunii, Wada, Matsumoto, Yang, Ikemoto (CR28) 2011; 35 Reuter, Weber, Fiebach, Elger, Montag (CR45) 2009; 202 Hemmings, Nairn, Bibb, Greengard (CR7) 1995 HC Hemmings (BFmp2012174_CR7) 1995 B Curčić-Blake (BFmp2012174_CR44) 2012; 59 ME Talkowski (BFmp2012174_CR35) 2008; 17 M Ishikawa (BFmp2012174_CR21) 2007; 31 X Guitart (BFmp2012174_CR47) 1992; 59 B Berger (BFmp2012174_CR2) 1990; 229 CM Lewis (BFmp2012174_CR29) 2003; 73 M Reuter (BFmp2012174_CR45) 2009; 202 A Meyer-Lindenberg (BFmp2012174_CR12) 2007; 117 K Yamada (BFmp2012174_CR33) 2007; 104 CB Chan (BFmp2012174_CR42) 2011; 31 P Svenningsson (BFmp2012174_CR1) 2004; 44 P Kauraniemi (BFmp2012174_CR15) 2003; 163 K Nishiura (BFmp2012174_CR28) 2011; 35 J Wang (BFmp2012174_CR17) 2004; 33 R Segurado (BFmp2012174_CR30) 2003; 73 Y Kunii (BFmp2012174_CR22) 2011; 44 MJ Frank (BFmp2012174_CR46) 2007; 104 C Ouimet (BFmp2012174_CR5) 1984; 4 Y Ebihara (BFmp2012174_CR16) 2004; 91 RG Cotton (BFmp2012174_CR8) 2008; 322 S Brene (BFmp2012174_CR3) 1995; 67 M Alvaro-Bartolomé (BFmp2012174_CR48) 2011; 196 C Konradi (BFmp2012174_CR39) 2011; 68 G Cuesto (BFmp2012174_CR41) 2011; 31 A Beckler (BFmp2012174_CR14) 2003; 98 L Gu (BFmp2012174_CR40) 2009; 4 KL Baracskay (BFmp2012174_CR23) 2006; 60 W El-Rifai (BFmp2012174_CR13) 2002; 62 B Vangamudi (BFmp2012174_CR19) 2010; 9 BK Lipska (BFmp2012174_CR37) 2006; 60 T Morikawa (BFmp2012174_CR10) 2010; 57 EL Heinzen (BFmp2012174_CR9) 2008; 6 KA Albert (BFmp2012174_CR20) 2002; 59 N Carrera (BFmp2012174_CR36) 2010; 179 SI Walaas (BFmp2012174_CR4) 1984; 4 HJ Kang (BFmp2012174_CR38) 2012; 18 A Yoshimi (BFmp2012174_CR34) 2008; 100 JE Kleinman (BFmp2012174_CR11) 2011; 69 L Zhan (BFmp2012174_CR25) 2011; 37 JX Hu (BFmp2012174_CR32) 2007; 31 LA Feldcamp (BFmp2012174_CR24) 2008; 103 CH Li (BFmp2012174_CR31) 2006; 87 Y Kunii (BFmp2012174_CR27) 2011; 35 A Belkhiri (BFmp2012174_CR43) 2008; 68 C Ouimet (BFmp2012174_CR6) 1992; 323 SM Clinton (BFmp2012174_CR26) 2005; 162 P Kauraniemi (BFmp2012174_CR18) 2006; 13 21878394 - Neuroimage. 2012 Jan 16;59(2):1540-50 18573638 - Schizophr Res. 2008 Aug;103(1-3):192-200 12124342 - Cancer Res. 2002 Jul 15;62(14):4061-4 21453742 - Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):1139-43 15363322 - Zhonghua Bing Li Xue Za Zhi. 2004 Aug;33(4):350-3 12802786 - Am J Hum Genet. 2003 Jul;73(1):34-48 17913879 - Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16311-6 17521792 - Prog Neuropsychopharmacol Biol Psychiatry. 2007 Aug 15;31(6):1177-81 7477907 - Neuroscience. 1995 Jul;67(1):37-48 21821092 - Prog Neuropsychopharmacol Biol Psychiatry. 2011 Dec 1;35(8):1901-7 16997002 - Biol Psychiatry. 2006 Sep 15;60(6):650-8 19593441 - PLoS One. 2009 Jul 13;4(7):e6220 18988827 - Science. 2008 Nov 7;322(5903):861-2 6319627 - J Neurosci. 1984 Jan;4(1):84-98 21183009 - Biol Psychiatry. 2011 Jan 15;69(2):140-5 17618027 - Prog Neuropsychopharmacol Biol Psychiatry. 2007 Aug 15;31(6):1303-6 14508844 - Cancer. 2003 Oct 1;98(7):1547-51 16199832 - Am J Psychiatry. 2005 Oct;162(10):1859-71 21414895 - J Neurosci. 2011 Feb 23;31(8):2721-33 12802785 - Am J Hum Genet. 2003 Jul;73(1):49-62 1494903 - J Neurochem. 1992 Sep;59(3):1164-7 18199533 - Cancer Res. 2008 Jan 15;68(2):395-403 14578197 - Am J Pathol. 2003 Nov;163(5):1979-84 15188007 - Br J Cancer. 2004 Jul 5;91(1):119-23 18045777 - Hum Mol Genet. 2008 Mar 1;17(5):747-58 16601278 - Endocr Relat Cancer. 2006 Mar;13(1):39-49 18055181 - Schizophr Res. 2008 Mar;100(1-3):334-41 21632930 - J Neurosci. 2011 Jun 1;31(22):8083-92 12150646 - Arch Gen Psychiatry. 2002 Aug;59(8):705-12 20483474 - Psychiatry Res. 2010 Sep 30;179(2):126-9 20813145 - Neurochem Int. 2010 Dec;57(7):691-704 16786528 - Synapse. 2006 Sep 15;60(4):271-9 17290303 - J Clin Invest. 2007 Mar;117(3):672-82 17360599 - Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2815-20 22179181 - Med Mol Morphol. 2011 Dec;44(4):190-9 2229482 - J Comp Neurol. 1990 Sep 15;299(3):327-48 20874815 - Neuropathol Appl Neurobiol. 2011 Feb;37(2):206-19 6319625 - J Neurosci. 1984 Jan;4(1):111-24 21925237 - Neuroscience. 2011 Nov 24;196 :1-15 19222302 - PLoS Biol. 2008 Dec 23;6(12):e1 1328330 - J Comp Neurol. 1992 Sep 8;323(2):209-18 22885997 - Nat Med. 2012 Sep;18(9):1413-7 14744247 - Annu Rev Pharmacol Toxicol. 2004;44:269-96 20836878 - Mol Cancer. 2010 Sep 13;9:240 19463699 - Behav Brain Res. 2009 Sep 14;202(2):179-83 21135314 - Arch Gen Psychiatry. 2011 Apr;68(4):340-50 16750903 - Schizophr Res. 2006 Oct;87(1-3):1-5 |
| References_xml | – volume: 103 start-page: 192 year: 2008 end-page: 200 ident: CR24 article-title: Reduced prefrontal cortex DARPP-32 mRNA in completed suicide victims with schizophrenia publication-title: Schizophr Res – volume: 59 start-page: 1164 year: 1992 end-page: 1167 ident: CR47 article-title: Chronic administration of lithium or other antidepressants increases levels of DARPP-32 in rat frontal cortex publication-title: J Neurochem doi: 10.1111/j.1471-4159.1992.tb08361.x – volume: 98 start-page: 1547 year: 2003 end-page: 1551 ident: CR14 article-title: Overexpression of the 32-kilodalton dopamine and cyclicadenosine 3′,5′-monophosphate-regulated phosphoprotein in common adenocarcinomas publication-title: Cancer doi: 10.1002/cncr.11654 – volume: 179 start-page: 126 year: 2010 end-page: 129 ident: CR36 article-title: Testing the antagonistic pleiotropy model of schizophrenia susceptibility by analysis of DAOA, PPP1R1B, and APOL1 genes publication-title: Psychiatry Res doi: 10.1016/j.psychres.2009.05.014 – volume: 31 start-page: 2721 year: 2011 end-page: 2733 ident: CR41 article-title: Phosphoinositide-3-kinase activation controls synaptogenesis and spinogenesis in hippocampal neurons publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4477-10.2011 – volume: 44 start-page: 269 year: 2004 end-page: 296 ident: CR1 article-title: DARPP-32: an integrator of neurotransmission publication-title: Annu Rev Pharmacol Toxicol doi: 10.1146/annurev.pharmtox.44.101802.121415 – volume: 229 start-page: 327 year: 1990 end-page: 348 ident: CR2 article-title: DARPP-32, a phosphoprotein enriched in dopaminoceptive neurons bearing D1 receptors: distribution in the cerebral cortex of newborn and adult rhesus monkey publication-title: J Comp Neurol doi: 10.1002/cne.902990306 – volume: 44 start-page: 190 year: 2011 end-page: 199 ident: CR22 article-title: Detailed DARPP-32 expression profiles in post-mortem brains from patients with schizophrenia: an immunohistochemical study publication-title: Med Mol Morphol doi: 10.1007/s00795-010-0524-1 – volume: 73 start-page: 49 year: 2003 end-page: 62 ident: CR30 article-title: Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: bipolar disorder publication-title: Am J Hum Genet doi: 10.1086/376547 – volume: 31 start-page: 8083 year: 2011 end-page: 8092 ident: CR42 article-title: Phosphoinositide 3-kinase enhancer regulates neuronal dendritogenesis and survival in neocortex publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1129-11.2011 – volume: 35 start-page: 1901 year: 2011 end-page: 1907 ident: CR28 article-title: Profiles of DARPP-32 in the insular cortex with schizophrenia: a postmortem brain study publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2011.07.010 – volume: 18 start-page: 1413 year: 2012 end-page: 1417 ident: CR38 article-title: Decreased expression of synapse-related genes and loss of synapses in major depressive disorder publication-title: Nat Med doi: 10.1038/nm.2886 – volume: 87 start-page: 1 year: 2006 end-page: 5 ident: CR31 article-title: Mutation analysis of DARPP-32 as a candidate gene for schizophrenia publication-title: Schizophrenia Res doi: 10.1016/j.schres.2006.04.003 – volume: 4 start-page: e6220 year: 2009 ident: CR40 article-title: Darpp-32 and its truncated variant t-Darpp have antagonistic effects on breast cancer cell growth and herceptin resistance publication-title: PLoS One doi: 10.1371/journal.pone.0006220 – volume: 91 start-page: 119 year: 2004 end-page: 123 ident: CR16 article-title: DARPP-32 expression arises after a phase of dysplasia in oesophageal squamous cellcarcinoma publication-title: Br J Cancer doi: 10.1038/sj.bjc.6601899 – volume: 73 start-page: 34 year: 2003 end-page: 48 ident: CR29 article-title: Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia publication-title: Am J Hum Genet doi: 10.1086/376549 – volume: 162 start-page: 1859 year: 2005 end-page: 1871 ident: CR26 article-title: Dopaminergic abnormalities in select thalamic nuclei in schizophrenia: involvement of the intracellular signal integrating proteins calcyon and spinophilin publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.162.10.1859 – volume: 60 start-page: 271 year: 2006 end-page: 279 ident: CR23 article-title: Dopamine receptor signaling molecules are altered in elderly schizophrenic cortex publication-title: Synapse doi: 10.1002/syn.20292 – volume: 13 start-page: 39 year: 2006 end-page: 49 ident: CR18 article-title: Activation of multiple cancer-associated genes at the ERBB2 amplicon in breast cancer publication-title: Endocr Relat Cancer doi: 10.1677/erc.1.01147 – volume: 31 start-page: 1303 year: 2007 end-page: 1306 ident: CR32 article-title: An association study between PPP1R1B gene and schizophrenia in the Chinese population publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2007.05.014 – volume: 17 start-page: 747 year: 2008 end-page: 758 ident: CR35 article-title: A network of dopaminergic gene variations implicated as risk factors for schizophrenia publication-title: Hum Mol Genet doi: 10.1093/hmg/ddm347 – volume: 9 start-page: 240 year: 2010 ident: CR19 article-title: t-DARPP regulates phosphatidylinositol-3-kinase-dependent cell growth in breast cancer publication-title: Mol Cancer doi: 10.1186/1476-4598-9-240 – volume: 37 start-page: 206 year: 2011 end-page: 219 ident: CR25 article-title: Altered expression and coregulation of dopamine signalling genes in schizophrenia and bipolar disorder publication-title: Neuropathol Appl Neurobiol doi: 10.1111/j.1365-2990.2010.01128.x – volume: 100 start-page: 334 year: 2008 end-page: 341 ident: CR34 article-title: Genetic analysis of the gene coding for DARPP-32 (PPP1R1B) in Japanese patients with schizophrenia or bipolar disorder publication-title: Schizophr Res doi: 10.1016/j.schres.2007.10.028 – volume: 4 start-page: 111 year: 1984 end-page: 124 ident: CR5 article-title: DARPP-32, a dopamine-and adenosine 3′:5′-monophosphate - regulated phosphoprotein enriched in dopamine-innervated brain regions, III: immunocytochemical localization publication-title: J Neurosci doi: 10.1523/JNEUROSCI.04-01-00111.1984 – volume: 322 start-page: 861 year: 2008 end-page: 862 ident: CR8 article-title: The Human Variome Project publication-title: Science doi: 10.1126/science.1167363 – volume: 60 start-page: 650 year: 2006 end-page: 658 ident: CR37 article-title: Critical factors in gene expression in postmortem human brain: focus on studies in schizophrenia publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2006.06.019 – volume: 6 start-page: e1 year: 2008 ident: CR9 article-title: Tissue-specific genetic control of splicing: implications for the study of complex traits publication-title: PLoS Biol doi: 10.1371/journal.pbio.1000001 – volume: 323 start-page: 209 year: 1992 end-page: 218 ident: CR6 article-title: Immunocytochemical localization of DARPP-32, a dopamine and cyclic AMP-regulated phosphoprotein, in the primate brain publication-title: J Comp Neurol doi: 10.1002/cne.903230206 – volume: 196 start-page: 1 year: 2011 end-page: 15 ident: CR48 article-title: Molecular adaptations of apoptotic pathways and signaling partners in the cerebral cortex of human cocaine addicts and cocaine-treated rats publication-title: Neuroscience doi: 10.1016/j.neuroscience.2011.08.074 – volume: 67 start-page: 37 year: 1995 end-page: 48 ident: CR3 article-title: Distribution of messenger RNAs for D1 dopamine receptors and DARPP-32 in striatum and cerebral cortex of the cynomolgus monkey:relationship to D1 dopamine receptors publication-title: Neuroscience doi: 10.1016/0306-4522(95)00037-J – start-page: 283 year: 1995 end-page: 297 ident: CR7 article-title: Signal transduction in the striatum: DARPP-32, a molecular integrator of multiple signaling pathways publication-title: Molecular and Cellular Mechanisms of Neostriatal Function – volume: 33 start-page: 350 year: 2004 end-page: 353 ident: CR17 article-title: Expression and significance of DARPP-32 in gastric carcinoma publication-title: Zhonghua Bing Li Xue Za Zhi – volume: 104 start-page: 2815 year: 2007 end-page: 2820 ident: CR33 article-title: Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0610765104 – volume: 57 start-page: 691 year: 2010 end-page: 704 ident: CR10 article-title: Aberrant regulation of alternative pre-mRNA splicing in schizophrenia publication-title: Neurochem Int doi: 10.1016/j.neuint.2010.08.012 – volume: 69 start-page: 140 year: 2011 end-page: 145 ident: CR11 article-title: Genetic neuropathology of schizophrenia: new approaches to an old question and new uses for postmortem human brains publication-title: Biol Psychiatry – volume: 59 start-page: 705 year: 2002 end-page: 712 ident: CR20 article-title: Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.59.8.705 – volume: 59 start-page: 1540 year: 2012 end-page: 1550 ident: CR44 article-title: Variation of the gene coding for DARPP-32 (PPP1R1B) and brain connectivity during associative emotional learning publication-title: Neuroimage doi: 10.1016/j.neuroimage.2011.08.036 – volume: 117 start-page: 672 year: 2007 end-page: 682 ident: CR12 article-title: Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition publication-title: J Clin Invest doi: 10.1172/JCI30413 – volume: 31 start-page: 1177 year: 2007 end-page: 1181 ident: CR21 article-title: Immunohistochemical and immunoblot analysis of dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32), in the prefrontal cortex of subjects with schizophrenia and bipolar disorder publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2007.04.013 – volume: 202 start-page: 179 year: 2009 end-page: 183 ident: CR45 article-title: The biological basis of anger: associations with the gene coding for DARPP-32 (PPP1R1B) and with amygdala volume publication-title: Behav Brain Res doi: 10.1016/j.bbr.2009.03.032 – volume: 163 start-page: 1979 year: 2003 end-page: 1984 ident: CR15 article-title: Amplification of a 280-kilobase core region at the ERBB2 locus leads to activation of two hypothetical proteins in breast cancer publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)63556-0 – volume: 4 start-page: 84 year: 1984 end-page: 98 ident: CR4 article-title: DARPP-32, a dopamine-and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions, I: regional and cellular distribution in the rat brain publication-title: J Neurosci doi: 10.1523/JNEUROSCI.04-01-00084.1984 – volume: 104 start-page: 16311 year: 2007 end-page: 16316 ident: CR46 article-title: Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0706111104 – volume: 68 start-page: 340 year: 2011 end-page: 350 ident: CR39 article-title: Hippocampal interneurons in bipolar disorder publication-title: Arch Gen Psychiatry doi: 10.1001/archgenpsychiatry.2010.175 – volume: 35 start-page: 1139 year: 2011 end-page: 1143 ident: CR27 article-title: Altered DARPP-32 expression in the superior temporal gyrus in schizophrenia publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2011.03.016 – volume: 68 start-page: 395 year: 2008 end-page: 403 ident: CR43 article-title: t-Darpp promotes cancer cell survival by up-regulation of Bcl2 through Akt-dependent mechanism publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-07-1580 – volume: 62 start-page: 4061 year: 2002 end-page: 4064 ident: CR13 article-title: Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP publication-title: Cancer Res – volume: 100 start-page: 334 year: 2008 ident: BFmp2012174_CR34 publication-title: Schizophr Res doi: 10.1016/j.schres.2007.10.028 – volume: 4 start-page: e6220 year: 2009 ident: BFmp2012174_CR40 publication-title: PLoS One doi: 10.1371/journal.pone.0006220 – volume: 35 start-page: 1139 year: 2011 ident: BFmp2012174_CR27 publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2011.03.016 – volume: 68 start-page: 340 year: 2011 ident: BFmp2012174_CR39 publication-title: Arch Gen Psychiatry doi: 10.1001/archgenpsychiatry.2010.175 – volume: 323 start-page: 209 year: 1992 ident: BFmp2012174_CR6 publication-title: J Comp Neurol doi: 10.1002/cne.903230206 – volume: 44 start-page: 190 year: 2011 ident: BFmp2012174_CR22 publication-title: Med Mol Morphol doi: 10.1007/s00795-010-0524-1 – volume: 31 start-page: 1303 year: 2007 ident: BFmp2012174_CR32 publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2007.05.014 – start-page: 283 volume-title: Molecular and Cellular Mechanisms of Neostriatal Function year: 1995 ident: BFmp2012174_CR7 – volume: 104 start-page: 2815 year: 2007 ident: BFmp2012174_CR33 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0610765104 – volume: 73 start-page: 34 year: 2003 ident: BFmp2012174_CR29 publication-title: Am J Hum Genet doi: 10.1086/376549 – volume: 60 start-page: 271 year: 2006 ident: BFmp2012174_CR23 publication-title: Synapse doi: 10.1002/syn.20292 – volume: 57 start-page: 691 year: 2010 ident: BFmp2012174_CR10 publication-title: Neurochem Int doi: 10.1016/j.neuint.2010.08.012 – volume: 104 start-page: 16311 year: 2007 ident: BFmp2012174_CR46 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0706111104 – volume: 18 start-page: 1413 year: 2012 ident: BFmp2012174_CR38 publication-title: Nat Med doi: 10.1038/nm.2886 – volume: 117 start-page: 672 year: 2007 ident: BFmp2012174_CR12 publication-title: J Clin Invest doi: 10.1172/JCI30413 – volume: 229 start-page: 327 year: 1990 ident: BFmp2012174_CR2 publication-title: J Comp Neurol doi: 10.1002/cne.902990306 – volume: 13 start-page: 39 year: 2006 ident: BFmp2012174_CR18 publication-title: Endocr Relat Cancer doi: 10.1677/erc.1.01147 – volume: 67 start-page: 37 year: 1995 ident: BFmp2012174_CR3 publication-title: Neuroscience doi: 10.1016/0306-4522(95)00037-J – volume: 202 start-page: 179 year: 2009 ident: BFmp2012174_CR45 publication-title: Behav Brain Res doi: 10.1016/j.bbr.2009.03.032 – volume: 33 start-page: 350 year: 2004 ident: BFmp2012174_CR17 publication-title: Zhonghua Bing Li Xue Za Zhi – volume: 35 start-page: 1901 year: 2011 ident: BFmp2012174_CR28 publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2011.07.010 – volume: 62 start-page: 4061 year: 2002 ident: BFmp2012174_CR13 publication-title: Cancer Res – volume: 69 start-page: 140 year: 2011 ident: BFmp2012174_CR11 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2010.10.032 – volume: 6 start-page: e1 year: 2008 ident: BFmp2012174_CR9 publication-title: PLoS Biol doi: 10.1371/journal.pbio.1000001 – volume: 31 start-page: 1177 year: 2007 ident: BFmp2012174_CR21 publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2007.04.013 – volume: 87 start-page: 1 year: 2006 ident: BFmp2012174_CR31 publication-title: Schizophrenia Res doi: 10.1016/j.schres.2006.04.003 – volume: 59 start-page: 705 year: 2002 ident: BFmp2012174_CR20 publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.59.8.705 – volume: 98 start-page: 1547 year: 2003 ident: BFmp2012174_CR14 publication-title: Cancer doi: 10.1002/cncr.11654 – volume: 73 start-page: 49 year: 2003 ident: BFmp2012174_CR30 publication-title: Am J Hum Genet doi: 10.1086/376547 – volume: 4 start-page: 111 year: 1984 ident: BFmp2012174_CR5 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.04-01-00111.1984 – volume: 103 start-page: 192 year: 2008 ident: BFmp2012174_CR24 publication-title: Schizophr Res doi: 10.1016/j.schres.2008.05.014 – volume: 9 start-page: 240 year: 2010 ident: BFmp2012174_CR19 publication-title: Mol Cancer doi: 10.1186/1476-4598-9-240 – volume: 31 start-page: 2721 year: 2011 ident: BFmp2012174_CR41 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4477-10.2011 – volume: 59 start-page: 1164 year: 1992 ident: BFmp2012174_CR47 publication-title: J Neurochem doi: 10.1111/j.1471-4159.1992.tb08361.x – volume: 37 start-page: 206 year: 2011 ident: BFmp2012174_CR25 publication-title: Neuropathol Appl Neurobiol doi: 10.1111/j.1365-2990.2010.01128.x – volume: 163 start-page: 1979 year: 2003 ident: BFmp2012174_CR15 publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)63556-0 – volume: 196 start-page: 1 year: 2011 ident: BFmp2012174_CR48 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2011.08.074 – volume: 179 start-page: 126 year: 2010 ident: BFmp2012174_CR36 publication-title: Psychiatry Res doi: 10.1016/j.psychres.2009.05.014 – volume: 44 start-page: 269 year: 2004 ident: BFmp2012174_CR1 publication-title: Annu Rev Pharmacol Toxicol doi: 10.1146/annurev.pharmtox.44.101802.121415 – volume: 91 start-page: 119 year: 2004 ident: BFmp2012174_CR16 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6601899 – volume: 59 start-page: 1540 year: 2012 ident: BFmp2012174_CR44 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2011.08.036 – volume: 322 start-page: 861 year: 2008 ident: BFmp2012174_CR8 publication-title: Science doi: 10.1126/science.1167363 – volume: 17 start-page: 747 year: 2008 ident: BFmp2012174_CR35 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddm347 – volume: 4 start-page: 84 year: 1984 ident: BFmp2012174_CR4 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.04-01-00084.1984 – volume: 31 start-page: 8083 year: 2011 ident: BFmp2012174_CR42 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1129-11.2011 – volume: 60 start-page: 650 year: 2006 ident: BFmp2012174_CR37 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2006.06.019 – volume: 162 start-page: 1859 year: 2005 ident: BFmp2012174_CR26 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.162.10.1859 – volume: 68 start-page: 395 year: 2008 ident: BFmp2012174_CR43 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-07-1580 – reference: 17521792 - Prog Neuropsychopharmacol Biol Psychiatry. 2007 Aug 15;31(6):1177-81 – reference: 14744247 - Annu Rev Pharmacol Toxicol. 2004;44:269-96 – reference: 20836878 - Mol Cancer. 2010 Sep 13;9:240 – reference: 18045777 - Hum Mol Genet. 2008 Mar 1;17(5):747-58 – reference: 21183009 - Biol Psychiatry. 2011 Jan 15;69(2):140-5 – reference: 6319627 - J Neurosci. 1984 Jan;4(1):84-98 – reference: 14578197 - Am J Pathol. 2003 Nov;163(5):1979-84 – reference: 12802785 - Am J Hum Genet. 2003 Jul;73(1):49-62 – reference: 7477907 - Neuroscience. 1995 Jul;67(1):37-48 – reference: 21821092 - Prog Neuropsychopharmacol Biol Psychiatry. 2011 Dec 1;35(8):1901-7 – reference: 21453742 - Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):1139-43 – reference: 18055181 - Schizophr Res. 2008 Mar;100(1-3):334-41 – reference: 21878394 - Neuroimage. 2012 Jan 16;59(2):1540-50 – reference: 12150646 - Arch Gen Psychiatry. 2002 Aug;59(8):705-12 – reference: 19593441 - PLoS One. 2009 Jul 13;4(7):e6220 – reference: 16997002 - Biol Psychiatry. 2006 Sep 15;60(6):650-8 – reference: 1328330 - J Comp Neurol. 1992 Sep 8;323(2):209-18 – reference: 19222302 - PLoS Biol. 2008 Dec 23;6(12):e1 – reference: 22179181 - Med Mol Morphol. 2011 Dec;44(4):190-9 – reference: 6319625 - J Neurosci. 1984 Jan;4(1):111-24 – reference: 20813145 - Neurochem Int. 2010 Dec;57(7):691-704 – reference: 2229482 - J Comp Neurol. 1990 Sep 15;299(3):327-48 – reference: 20874815 - Neuropathol Appl Neurobiol. 2011 Feb;37(2):206-19 – reference: 14508844 - Cancer. 2003 Oct 1;98(7):1547-51 – reference: 17913879 - Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16311-6 – reference: 21135314 - Arch Gen Psychiatry. 2011 Apr;68(4):340-50 – reference: 1494903 - J Neurochem. 1992 Sep;59(3):1164-7 – reference: 17360599 - Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2815-20 – reference: 22885997 - Nat Med. 2012 Sep;18(9):1413-7 – reference: 21925237 - Neuroscience. 2011 Nov 24;196 :1-15 – reference: 17618027 - Prog Neuropsychopharmacol Biol Psychiatry. 2007 Aug 15;31(6):1303-6 – reference: 18199533 - Cancer Res. 2008 Jan 15;68(2):395-403 – reference: 19463699 - Behav Brain Res. 2009 Sep 14;202(2):179-83 – reference: 12802786 - Am J Hum Genet. 2003 Jul;73(1):34-48 – reference: 18573638 - Schizophr Res. 2008 Aug;103(1-3):192-200 – reference: 15363322 - Zhonghua Bing Li Xue Za Zhi. 2004 Aug;33(4):350-3 – reference: 21632930 - J Neurosci. 2011 Jun 1;31(22):8083-92 – reference: 16786528 - Synapse. 2006 Sep 15;60(4):271-9 – reference: 12124342 - Cancer Res. 2002 Jul 15;62(14):4061-4 – reference: 16199832 - Am J Psychiatry. 2005 Oct;162(10):1859-71 – reference: 18988827 - Science. 2008 Nov 7;322(5903):861-2 – reference: 17290303 - J Clin Invest. 2007 Mar;117(3):672-82 – reference: 20483474 - Psychiatry Res. 2010 Sep 30;179(2):126-9 – reference: 16601278 - Endocr Relat Cancer. 2006 Mar;13(1):39-49 – reference: 15188007 - Br J Cancer. 2004 Jul 5;91(1):119-23 – reference: 21414895 - J Neurosci. 2011 Feb 23;31(8):2721-33 – reference: 16750903 - Schizophr Res. 2006 Oct;87(1-3):1-5 |
| SSID | ssj0014765 |
| Score | 2.352267 |
| Snippet | Dopamine- and cAMP-regulated phosphoprotein of molecular weight 32 kDa (DARPP-32 or
PPP1R1B
) has been of interest in schizophrenia owing to its critical... Dopamine- and cAMP-regulated phosphoprotein of molecular weight 32 kDa (DARPP-32 or PPP1R1B) has been of interest in schizophrenia owing to its critical... Dopamine- and cAMP-regulated phosphoprotein of molecular weight 32 kDa (DARPP-32 or PPP1R1B) has been of interest in schizophrenia owing to its critical... |
| SourceID | proquest gale pubmed pascalfrancis crossref springer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 192 |
| SubjectTerms | 631/208/2489/144 692/699/476 Adolescent Adult Adult and adolescent clinical studies Affective disorders Aged Aged, 80 and over Alternative splicing Animals Antipsychotic Agents - pharmacology Behavioral Sciences Biological and medical sciences Biological Psychology Bipolar disorder Bipolar Disorder - genetics Bipolar Disorder - metabolism Bipolar disorders Brain - drug effects Brain - growth & development Brain - metabolism Brain research Child Child, Preschool Cognition & reasoning Cognitive ability DARPP-32 protein Depressive Disorder, Major - genetics Depressive Disorder, Major - metabolism Dopamine Dopamine and cAMP-Regulated Phosphoprotein 32 - genetics Dopamine and cAMP-Regulated Phosphoprotein 32 - metabolism Dopamine receptors Female Fetus Gene expression Genes Genetic aspects Genetic diversity Genetic research Haplotypes Humans Infant Kinases Male Medical sciences Medicine Medicine & Public Health Mental disorders Mental health Middle Aged Miscellaneous Molecular modelling Molecular weight Mood disorders Neuroimaging Neurosciences original-article Pharmacotherapy Phenotypes Phosphatase Phosphorylation Physiology Prefrontal cortex Proteins Psychiatry Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychoses Psychosis Rats Rats, Sprague-Dawley Schizophrenia Schizophrenia - drug therapy Schizophrenia - genetics Schizophrenia - metabolism Single-nucleotide polymorphism |
| Title | Revisiting DARPP-32 in postmortem human brain: changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expression |
| URI | https://link.springer.com/article/10.1038/mp.2012.174 https://www.ncbi.nlm.nih.gov/pubmed/23295814 https://www.proquest.com/docview/1491273653 https://www.proquest.com/docview/2645766183 https://www.proquest.com/docview/1492705159 https://www.proquest.com/docview/1496881825 |
| Volume | 19 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ta9swEBZby2BQxt7rtQ0adAwGorEkS3a_jHRrKYOVEFbINyPLMhQWx5td2P7FfvLuZMVpaOjX6GLZutPpHul0DyHH3BnnRCxYxa1jMtYxK6SyzAkrhSxTXRrch_x-pS6v5bd5Mg8bbm1Iq1z5RO-oy6XFPfITiORjWGpVIj43vxiyRuHpaqDQeEx2sXQZpnTp-QC4Yqk9lWQsEjztTGW4nzcW6ckCa1XGHPN5Nlak4Jf3GtPCGFU9ucW26PPeyalfkC6ek2chkqSTXvUvyCNXvyRPem7Jv6_Iv5m_N45ZzfTrZDadMsHpTU2bZdstfIYt9fx8tECSiFPa3wBuUaS9m4hHTV3S4qZBCEzLUKvT_wimhzcgqVlruKW4r0s7NvTo_oRM2_o1ub44__HlkgX6BWYBNHaMm6pKCykLrlLEbciQAT4JIr5irDivKoPo0AldAOSqBIQeoF5ltM5SbgBFiTdkp17Wbp_QqkwtNxKgpobwK8OafRme-Y51lmlTjSPyaaWC3Iba5EiR8TP3Z-QizRdNjvrKQV8ROR6Em74kx3axj6jLHCcqPMuacN8A3ghLXuUToQBcITloRA43JGGC2Y3m0YY1DJ1CZJYlidbw_5V55MEDtPnaXrc2QxwKSE-BQ43I-6EZe8akt9otb_0juEYOnuxBGQU6AZwfkbe9Za7fT3CYEzGMxIeVqd55v_sj9u7h7zggT0FS9inrh2Sn-33rjiAi64qRn3Yjsnt2fjWd_Qc-1jFv |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3batwwEBVpQmmhlN7jNk1VSCgURGxJtuRCKdsmYdMky7IkkDdXtmUIZL1u7dDmL_ol_cbO-LZZsuQtr5YsyZ7RaEZzOYRscWusFZ5gGU8sk57yWCyDhFmRSCFTrVKD95DHo2B4Kr-f-Wcr5F-XC4NhlZ1MrAV1OkvwjnwHNHkPjtrAF1-KnwxRo9C72kFoNGxxaK9-g8lWfj7YBfpuc76_d_JtyFpUAZaALVQxbrJMx1LGPNBojiDwA2w1UGRiN-A8ywwaPVaoGCyJTMCJCqsOjFKh5gaMAwHj3iNr8MwFQbD2dW80nvR-C6lq8EoYE_2rWrYZga7QO1OsjulxjCBaOAPbk-BRYUqgStbAaSzTd2_4ausjcP8JedzqrnTQMNtTsmLzZ-R-g2Z59Zz8ndSZ6hhHTXcHk_GYCU7Pc1rMympax_TSGhGQxghL8Yk2Occldimvh_5Rk6c0Pi_Q6KZpWx20fgjMjjmX1Mx5qqR4k0wr1s9o_7SxvfkLcnonpHlJVvNZbtcJzVKdcCPBuFWg8IVYJTBEL7OrwlCZzHXIx44EUdJWQ0dQjouo9soLHU2LCOkVAb0cstV3LpoiIMu7fUBaRigaYKzEtBkOsCIsshUNRADmHMKROmRjoSds6WSheXOBG_pJQRcMfV8peL9jj6iVOWU03yFLm0HzBdsyABHukPd9M86MYXa5nV3WQ3CFqD_hrX0CoInmvkNeNZw5X5_goa89-BPbHateW9_NP_b69u94Rx4MT46PoqOD0eEb8hDekk3A_AZZrX5d2regD1bxZrsJKflx1_v-Pwoaaoo |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3_a9QwFA9zoggifl91zggbghDumqRNK4gcnsfmdBzDwf1W0zaBwa5XbYfuv_Dv8a_zvfTL7dix3_ZrkyZp33vJe3lfPoTscqONEb5glmeGSV_5LJVhxozIpJB5pHKN95DfjsL9E_llFsw2yL8uFwbDKrs90W3U-SLDO_IBaPI-HLVhIAa2DYuYjicfy58MEaTQ09rBaTQscmgufoP5Vn04GAOt9ziffP7-aZ-1CAMsA7uoZlxbG6VSpjyM0DRBEAgQO1Bq0mHIubUaDSAjVApWhRVwusIXhFqpOOIaDAUB494it5UIfJQxNeuNPV8qB2MJI6KnNZJtbuBQRIM51sn0OcYSrZyG7Zlwv9QV0Mc2wBrrNN8rXlt3GE4ekgetFktHDds9IhumeEzuNLiWF0_I32OXs44R1XQ8Op5OmeD0tKDloqrnLrqXOmxAmiJAxXvaZB9X2KW6HARIdZHT9LRE85vmbZ1Q9xDYHrMvqV5yV0XxTpnWrJ_R_GmjfIun5ORGCPOMbBaLwmwRavMo41qCmatA9YuxXmCM_uahimOl7dAj7zoSJFlbFx3hOc4S558XUTIvE6RXAvTyyG7fuWzKgazv9hZpmeAmAWNlus11gBVhua1kJEIw7BCY1CPbKz1BuLOV5p0VbugnBa0wDgKl4P2OPZJ296mSpaysbQYdGKzMEDZzj7zpm3FmDLgrzOLcDcEV4v_E1_YJgSYRDzzyvOHM5foEj4PIhz-x17HqpfVd_WMvrv-O1-QuSHvy9eDo8CW5By_JJnJ-m2zWv87NK1AM63THSSAlP25a5P8DOBNtWg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Revisiting+DARPP-32+in+postmortem+human+brain%3A+changes+in+schizophrenia+and+bipolar+disorder+and+genetic+associations+with+t-DARPP-32+expression&rft.jtitle=Molecular+psychiatry&rft.au=KUNII%2C+Y&rft.au=HYDE%2C+T.+M&rft.au=YE%2C+T&rft.au=LI%2C+C&rft.date=2014-02-01&rft.pub=Nature+Publishing+Group&rft.issn=1359-4184&rft.volume=19&rft.issue=2&rft.spage=192&rft.epage=199&rft_id=info:doi/10.1038%2Fmp.2012.174&rft.externalDBID=n%2Fa&rft.externalDocID=28395577 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1359-4184&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1359-4184&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1359-4184&client=summon |